Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating yin deficiency and heat-poison type lung cancer and preparation method thereof

A drug and toxic heat technology, applied in the field of pharmacy, can solve the problems of poor patient tolerance, poor selectivity of chemotherapeutic drugs, damage to human righteousness, etc., and achieve the effects of improving quality of life, good anti-cancer activity, and no toxic side effects.

Inactive Publication Date: 2015-06-10
郝红
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, Western medicine has certain advantages in shrinking tumors, but it is limited in improving the quality of life of patients. At the same time, it seriously damages the human body's righteousness, and the selectivity of chemotherapy drugs is poor. During chemotherapy, liver function and gastrointestinal digestive function may be damaged. Injuries, etc., patients are often forced to discontinue treatment due to poor tolerance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] Example 1 tablet

[0050] The embodiment of the present invention provides a medicine for treating yin deficiency and toxic heat type lung cancer, which is made of the following raw materials in parts by weight: 23 parts by weight of spider plant, 16 parts by weight of moss moss, 16 parts by weight of pearl ginseng, 20 parts by weight of wolfberry leaves, 13 parts by weight of black sun ginseng, 15 parts by weight of dandelion, 21 parts by weight of forsythia, 15 parts by weight of calla lily, 16 parts by weight of hollyhock root, 13 parts by weight of cat's claw, 22 parts by weight of ants, loquat 6 parts by weight of taro, 16 parts by weight of American ginseng, 18 parts by weight of wheat bottle grass, 13 parts by weight of red eclipta, 17 parts by weight of loofah seeds and 16 parts by weight of walnut kernel;

[0051] Its preparation method comprises the following steps:

[0052] The first step is to weigh the calla lily by weight, put the calla lily into 4 times ...

Embodiment 2

[0056] Embodiment 2 drop pills

[0057] The embodiment of the present invention provides a medicine for treating lung cancer of yin deficiency and toxin-heat type, which is made of the following raw materials in parts by weight: 23 parts by weight of Chlorophytum chinensis, 16 parts by weight of Moss chinensis, 16 parts by weight of Pearl Ginseng, 20 parts by weight of wolfberry leaves, 13 parts by weight of black sun ginseng, 15 parts by weight of dandelion, 21 parts by weight of forsythia, 15 parts by weight of calla lily, 16 parts by weight of hollyhock root, 13 parts by weight of cat's claw, 22 parts by weight of ants, loquat 6 parts by weight of taro, 16 parts by weight of American ginseng, 18 parts by weight of wheat bottle grass, 13 parts by weight of red eclipta, 17 parts by weight of loofah seeds, 16 parts by weight of walnut kernel, 15 parts by weight of litchi vine, 23 parts by weight of Ganoderma lucidum, 13 parts by weight of oatmeal parts by weight and 11 parts b...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating yin deficiency and heat-poison type lung cancer and a preparation method thereof. The medicine comprises the following raw medicinal materials: chlorophytum comosum, oreas martiana (hopp. et hornsch.) brid., panax pseudo-ginseng wsll. var, holly leaf, dunn antiotrema root, dandelion, fructus forsythia, alocasia, althea root, radix ranunculi ternate, ant, rhizome of himalayan xylanche, American ginseng, silene conoidea, herba hyperici, luffa seed and walnut kernel. The medicine provided by the invention has the effects of replenishing the vital essence and removing heat, removing toxic material and removing stasis, warming the kidney and tonifying Qi, cooling blood and hemostasis, and moistening dryness and relaxing the bowels; furthermore, the medicine for treating yin deficiency and heat-poison type lung cancer has the advantages of being good in antitumor activity, high in safety, being free from toxic and side effects, the living quality of a patient can be improved.

Description

technical field [0001] The invention relates to the technical field of pharmacy, in particular to a medicine for treating lung cancer of yin deficiency and toxin-heat type and a preparation method thereof. Background technique [0002] Lung cancer is one of the most common clinical malignant tumors. Lung cancer has a high degree of malignancy. It is one of the malignant tumors with the fastest growth in morbidity and mortality and the greatest threat to the health and life of the population. In the past 50 years, many countries have reported that the morbidity and mortality of lung cancer have increased significantly. The incidence and mortality of lung cancer in men rank first among all malignant tumors, and the incidence and mortality of lung cancer occupy the second place in women. The etiology of lung cancer is still not completely clear. A large number of data show that long-term heavy smoking has a very close relationship with the occurrence of lung cancer. Existing...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/898A61K36/899A61P11/00A61P35/00A61K35/64
Inventor 郝红
Owner 郝红
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products